BIONEWS
BINEWS
BIOMEX at the ASGCT 2025!
BIOMEX is excited to announce our first-ever presence at the ASGCT Annual Meeting – the American Society of Gene & Cell Therapy – taking place
CACLP 2025: Thank You for the Great Exchange!
We would like to extend our sincere thanks to all customers and interested visitors for the engaging conversations and valuable exchange during CACLP 2025, held
BIOMEX study team becomes IVD TRIALS GmbH!
Until December 31, 2024, the BIOMEX study team was an integral part of BIOMEX, delivering exceptional clinical IVD study services. As of January 1, 2025,
Welcome to BIOMEX, Thomas Matthes!
We are excited to introduce Thomas Matthes as the new Director of the Life Sciences Business Unit at BIOMEX. With over 30 years of experience
Save the Date! Meet BIOMEX at CACLP 2025
We are excited to announce that BIOMEX will once again be part of CACLP 2025 in China! Are you looking for expert guidance on European
End of the Year Wrap-Up 2024
As 2024 comes to an end, we take a moment to reflect on the milestones and achievements that marked this year, all while staying true
BIMEX Journey
#BIOMEXjourney
Always stay up to date. Here we provide news from inside and outside BIOMEX. “Join our Journey” is our campaign on LinkedIn. Here we share progress in tissues, PBMCs and cfDNA – our new market segment for the Life Sciences industry.
Stay connected with BIOMEX and our team on LinkedIn.
Newsletter
Have you already subscribed to our email newsletter?
You will receive more interesting market information and important updates:
